16-Dec-2016
Friends of the Earth International
RCEP also includes the controversial Investor-State Dispute Settlement mechanism (ISDS), which is facing increasing public criticism and scrutiny worldwide.
16-Dec-2016
infojustice.org
Reflections on the 16th RCEP negotiations in Indonesia
15-Dec-2016
The Hindu Businessline
Round in Indonesia fails to generate breakthrough in final numbers
14-Dec-2016
The Economic Times
The members common to two agreements (TPP and RCEP), especially developed countries such as Australia, Japan and New Zealand, want talks at the RCEP trade bloc to move ahead full steam
13-Dec-2016
Asian Peasant Coalition
Groups vow not to pass RCEP
12-Dec-2016
The Times of India
Doctors Without Borders/Medecins Sans Frontieres (MSF) and other health groups have reiterated concerns about harmful intellectual property provisions in the RCEP
9-Dec-2016
The Straits Times
Negotiations for the Regional Comprehensive Economic Partnership (RCEP), championed by China, will likely be substantially concluded by the end of next year, Malaysia’s International Trade and Industry Minister Mustapa Mohamed said.
9-Dec-2016
Bloomberg Quint
Matters such as intellectual property rights, as well as trade in goods and services, remain unresolved. The next talks will be held in Japan in February.
7-Dec-2016
The Jakarta Post
Amid the collapse of the United States-backed Trans-Pacific Partnership (TPP) pact, trade officials from 10 Southeast Asian countries and six key partners started on Tuesday talks on a rival deal with new urgency.
7-Dec-2016
Forum Against FTAs
Why is the Indian government signing the RCEP agreement, which allows foreign investors to sue governments, threatens access to life-saving medicines and puts at risk seed sovereignty?
6-Dec-2016
The Jakarta Post
As trade negotiators from 16 countries gather in Indonesia to deliberate the terms of trade agreement — the Regional Comprehensive Economic Partnership agreement (RCEP), access to low-cost generic medicines is under grave threat.
5-Dec-2016
Médecins Sans Frontières
International medical humanitarian organisation Médecins Sans Frontières (MSF), along with other health groups, reiterated concerns about harmful intellectual property provisions in the proposed agreement that would increase market monopolies for pharmaceutical corporations and delay or block access to affordable generic medicines.
